Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
JACC. Advances|January 1, 2025
Consequences of Recurrent Hyperkalemia on Cardiovascular Outcomes and MortalityGeorge Bakris, Abiy Agiro, Fan Mu, et al.
JAMA|July 11, 2013
Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and OntarioDennis T Ko, Jack V Tu, Peter C Austin, et al.
Cancer|January 9, 2020
Assessing the efficacy-effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population-based, real-world data for contemporary parenteral cancer therapeuticsCameron M Phillips, Ambica Parmar, Helen Guo, et al.
The American Journal of Managed Care|March 28, 2014
Evaluation of Electronic Medical Record Administrative data Linked Database (EMRALD)Karen Tu, Tezeta F Mitiku, Noah M Ivers, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 6, 2023
Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL)Hetalkumari Patel, Svea K Wahlstrom, Maral DerSarkissian, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Family history, mammographic density, and risk of breast cancerLisa J Martin, Olga Melnichouk, Helen Guo, et al.
The Canadian Journal of Cardiology|June 28, 2014
Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and womenDennis T Ko, Harindra C Wijeysundera, Jacob A Udell, et al.
Annals of Internal Medicine|January 2, 2013
Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studiesPrateek J Khatri, John G Webb, Josep Rodés-Cabau, et al.
American Heart Journal|October 8, 2013
Predictors of normal coronary arteries at coronary angiographyKevin Levitt, Helen Guo, Harindra C Wijeysundera, et al.
Blood Advances|May 10, 2023
Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemiaLindsey E Roeker, Maral DerSarkissian, Kellie Ryan, et al.
Pageof 5